Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Display Technologies for Generation of Ig Single Variable DomainsVladimir Bobkov, Bas van der Woning, Hans de HaardMolecular Pharmacology|September 5, 2019
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3Vladimir Bobkov, Marta Arimont, Aurélien Zarca, et al.Mabs|May 24, 2016
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loopsBas van der Woning, Gitte De Boeck, Christophe Blanchetot, et al.Communications Biology|December 16, 2025
TR-FRET between engineered nanobodies reveals the existence of endogenous CXCR4 oligomersJoyce Heuninck, Vladimir Bobkov, Claire M Grison, et al.Biochemical Pharmacology|October 21, 2018
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functionsVladimir Bobkov, Aurelien M Zarca, Anneleen Van Hout, et al.Biochemical Pharmacology|October 21, 2018
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entryAnneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov, et al.Science (New York, N.Y.)|October 27, 2018
Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cellsStéphanie Liénart, Romain Merceron, Christophe Vanderaa, et al.Oncoimmunology|November 17, 2022
Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapyAngélique Vienot, Jean-René Pallandre, Elodie Renaude, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2017
Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgAOlivier Dedobbeleer, Julie Stockis, Bas van der Woning, et al.Cells|May 28, 2022
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.Pageof 8